IONS - Ionis Pharma Long-Term Debt Volume

Brandmark of Ionis Pharma (IONS)

The deployment of robotic systems for oligonucleotide synthesis is accelerating the search for RNA targets for Ionis Pharmaceuticals (IONS). The company's long-term debt metric reflects liability dynamics, with the current mark standing at 2.10. Business resilience is underpinned by a US-based manufacturing footprint and partnerships with industry behemoths. High-margin royalties from licenses and a diversified portfolio of genetic drugs establish the financial foundation.

Ionis Pharmaceuticals, Inc. (IONS) Company Long-Term Debt: for the period 07/04/2022 - 10/29/2026

Summary analytical data breakdowns for Ionis Pharma (IONS)

- market price and analyst price targets:
Stock Price ionispharma.com|IONS - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Ionis|IONS - Total Company Value
- balance sheet equity data:
Net Asset Value per Share Ionis|IONS - Company Book Value|Capitalization to Book Value Ratio ionispharma.com|IONS - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Capital Coefficient Ionis Pharmaceuticals|IONS - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Isis Pharmaceuticals|IONS - Company Total Debt|Debt to Net Assets Ratio Ionis|IONS - Company Long-Term Debt|Current Liabilities Ionis
Fundamental company valuation:ionispharma.com
Signature product of Ionis Pharmaceuticals

Investors must evaluate the capital stability of Ionis Pharmaceuticals (IONS) by analyzing its debt load. This metric measures the total volume of obligations with a maturity of over one year, determining financial leverage and the cost of debt service. By analyzing the status of the corporation's long-term loans and borrowings, one can assess borrowing rates. This is critical for Ionis Pharmaceuticals (IONS), which utilizes debt to finance the intensive development of innovative RNA therapies for the treatment of rare pathologies.

Competitors of Ionis Pharmaceuticals (IONS)

Company Long-Term Debts Tempus Labs TEM|Qiagen - Company Long-Term Debts|Long-Term Debt Volume Repligen Corp RGEN|Avidity (RNA) - Company Long-Term Debt|Long-Term Debt CRISPR (CRSP)|Company Long-Term Debt GeneDx Holdings Corp.|Company Long-Term Indebtedness RARE (ultragenyx.com)|Company Long-Term Debts BEAM|Long-Term Debt Volume Sarepta Therapeutics|Company Long-Term Debt Twist Bio TWST|Long-Term Debt Volume 10x (TXG)|NTLA: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings STOK (stoketherapeutics.com)|BioLife Solutions (BLFS) - Company Long-Term Debt|Long-Term Liabilities WVE (Wave Life Sciences Ltd)|MAZE (Maze Tx) - Company Long-Term Debts|SION: Company Long-Term Loans and Borrowings|Company Long-Term Debts PRME|Company Long-Term Debts tayshagtx.com (TSHA)|Company Long-Term Debt uniQure QURE|Company Long-Term Loans and Borrowings MGTX|RGNX - Company Long-Term Debt|Solid Corp (SLDB) - Company Long-Term Liabilities|OCGN: Company Long-Term Debts|pacb.com (PACB) - Company Long-Term Debts|BNTC (Benitec Biopharma) - Company Long-Term Debts|Company Long-Term Liabilities Design Therapeutics Inc (DSGN)|Company Long-Term Debts RCKT|FDMT - Long-Term Debt|Lexeo Therapeutics, Inc. - Company Long-Term Liabilities|Company Long-Term Debts Korro Bio Inc. KRRO|EDIT: Company Long-Term Liabilities|Silence Therapeutics PLC - Amount of Long-Term Liabilities|PRQR: Company Long-Term Debts|CDXS - Long-Term Debt Volume|SGMO (Sangamo Therapeutics) - Company Long-Term Debts|Company Long-Term Liabilities Nautilus Biotechnology Inc (NAUT)|Company Long-Term Debts MGX|Company Long-Term Debts Precision BioSciences Inc. (DTIL)|Company Long-Term Debt Generation Bio GBIO|Boundless Bio Inc - Company Long-Term Debt|XCUR - Company Long-Term Debt|Long-Term Debt Volume Imunon, Inc. IMNN|PHIO: Company Long-Term Debts|MBIO - Long-Term Debt Volume|Company Long-Term Debt TransCode Therapeutics Inc.|Long-Term Debt Bionano BNGO|Company Long-Term Debt Applied DNA Sciences (APDN)|bluebirdbio.com - Company Long-Term Indebtedness|Company Long-Term Debt ImmunoPrecise Antibodies Ltd. IPA|Long-Term Debt Volume Omega Therapeutics Inc (OMGA)|Singular Genomics Systems Inc - Company Long-Term Debts|RGLS (Regulus) - Company Long-Term Indebtedness|Syros Pharmaceuticals (SYRS) - Company Long-Term Debt|Company Long-Term Indebtedness TBIO|TCON (TRACON Pharmaceuticals, Inc.) - Company Long-Term Debts|Company Long-Term Debts Unity Biotechnology Inc.